ENPP7P10: A Drug Target / Disease Biomarker (G100421805)

Target Name: ENPP7P10

NCBI ID: G100421805

ENPP7P10

Other Name(s): ectonucleotide pyrophosphatase/phosphodiesterase 7 pseudogene 10 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 pseudogene 10

ENPP7P10: A Drug Target / Disease Biomarker

ENPP7P10 is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the ENPP family, which includes proteins that are involved in the regulation of inflammation and pain.

One of the functions of ENPP7P10 is to regulate the production of pro-inflammatory cytokines, which are molecules that play a key role in the inflammatory response. These cytokines can cause inflammation, pain, and other cellular changes in the body, and they are often associated with a range of diseases, including heart disease, cancer, and neurological disorders.

ENPP7P10 is also involved in the regulation of the production of anti-inflammatory cytokines, which help to counteract the pro-inflammatory effects of cytokines. These cytokines can help to reduce inflammation and pain, and they are often associated with a range of health benefits, including protection against infection, autoimmune diseases, and certain types of cancer.

In addition to its role in cytokine regulation, ENPP7P10 is also involved in the regulation of cellular signaling pathways that are involved in inflammation and pain. These pathways can involve the production of pro-inflammatory cytokines, as well as the production of other signaling molecules that can contribute to inflammation and pain.

Overall, ENPP7P10 is a protein that is involved in a range of physiological processes that are important for maintaining the health and function of the body. As a result, it is a potential drug target or biomarker for a variety of diseases.

Protein Name: Ectonucleotide Pyrophosphatase/phosphodiesterase 7 Pseudogene 10

The "ENPP7P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ENPP7P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets